Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Current Leases (2019 - 2025)

Historic Current Leases for BioCorRx (BICX) over the last 7 years, with Q3 2025 value amounting to $41686.0.

  • BioCorRx's Current Leases rose 616.31% to $41686.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $41686.0, marking a year-over-year increase of 616.31%. This contributed to the annual value of $40057.0 for FY2024, which is 6736.22% down from last year.
  • As of Q3 2025, BioCorRx's Current Leases stood at $41686.0, which was up 616.31% from $41686.0 recorded in Q2 2025.
  • In the past 5 years, BioCorRx's Current Leases ranged from a high of $146187.0 in Q3 2023 and a low of $38491.0 during Q2 2024
  • In the last 5 years, BioCorRx's Current Leases had a median value of $116276.0 in 2021 and averaged $98363.3.
  • As far as peak fluctuations go, BioCorRx's Current Leases skyrocketed by 3792.27% in 2021, and later plummeted by 7313.99% in 2024.
  • BioCorRx's Current Leases (Quarter) stood at $119733.0 in 2021, then rose by 12.2% to $134343.0 in 2022, then dropped by 8.64% to $122732.0 in 2023, then crashed by 67.36% to $40057.0 in 2024, then rose by 4.07% to $41686.0 in 2025.
  • Its last three reported values are $41686.0 in Q3 2025, $41686.0 for Q2 2025, and $40863.0 during Q1 2025.